CPCristiane Figueiredo Pinho

Cristiane Figueiredo Pinho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cristiane Figueiredo Pinho has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effects of endocrine disrupting chemicals on inflammation and oxidative stress in the prostate: an overview in different experimental models

    by Ana Clara Pacheco de Santana, Eleonora Pizzo Liboni, Vinícius Luis Rocha da Silva Maria, Sergio Pereira, Cristiane Figueiredo Pinho

    Background: Endocrine-disrupting chemicals (EDCs) are environmental pollutants capable of interfering with hormonal regulation and affecting the homeostasis of hormone-dependent organs such as the prostate. Increasing evidence links exposure to EDCs with prostate inflammation, oxidative stress, and carcinogenesis. These compounds, found in pesticides, plastics, surfactants, and heavy metals, act through diverse molecular pathways that disrupt endocrine, immune, and metabolic functions. Purpose of Review: From this perspective, the present review aims to synthesize current findings on the effects of EDCs on inflammation and oxidative stress in the prostate, highlighting experimental evidence from in vitro and in vivo models and discussing the main molecular mechanisms involved. Recent Findings: Recent studies have strengthened the evidence that EDCs play a critical role in prostate pathophysiology by integrating inflammatory, oxidative, and epigenetic mechanisms. Advances in molecular biology have revealed that EDC exposure can modulate key signaling pathways, including NF-κB, TLR4, and TNF-α, leading to sustained inflammatory responses and disruption of redox homeostasis in prostatic cells. Results: Experimental studies demonstrate that EDCs such as bisphenol A, phthalates, nonylphenol, cadmium, arsenic, and vinclozolin induce inflammatory and oxidative alterations in prostate tissue. These effects include activation of pro-inflammatory signaling pathways, increased expression of cytokines, and upregulation of oxidative stress markers. Concurrently, these compounds impair antioxidant defense systems by modulating enzymes such as catalase, superoxide dismutase, and glutathione reductase. Chronic exposure promotes cellular proliferation, epithelial dysplasia, apoptotic resistance, and epigenetic modifications, contributing to prostate pathogenesis and tumorigenesis. Conclusion: EDCs exert profound effects on prostatic physiology by disrupting endocrine balance, promoting chronic inflammation, and inducing oxidative stress. The interplay between these processes establishes a microenvironment favorable to cellular transformation and tumor progression.


  • Arsenic exposure during prepuberty alters prostate maturation in pubescent rats

    by Ariana M. Aquino, Giovanna C. Salata, Cristiane F. Pinho, André T.A.G. de Freitas, Larissa L. Périco, Gláucia E.M. de Lion Siervo, Leonardo O. Mendes, Paloma Da Cunha De Medeiros, Luís A. Justulin, Glaura S.A. Fernandes, et al.


  • Panax ginseng methabolit (GIM-1) prevents oxidative stress and apoptosis in human Sertoli cells exposed to Monobutyl-phthalate (MBP)

    by André Teves A.G. DE Freitas, Cristiane Figueiredo Pinho, Ariana Musa de Aquino, Ana Angélica H. Fernandes, Raquel Fantin Domeniconi, Luis Antonio Justulin, Wellerson Rodrigo Scarano


  • Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30/GPER1 involvement

    by Giovanna Cassone Salata, Cristiane Figueiredo Pinho, André T A G de Freitas, Ariana Musa Aquino, Luis Antonio Justulin, Leonardo Oliveira Mendes, Bianca F. Gonçalves, Flávia Karina Delella, Wellerson Rodrigo Scarano

    Objectives: This study evaluated raloxifene (ral) effects on LNCaP prostate tumour cells modulating the activity of GPER1/GPR30 receptors. Methods: LNCaP cells were submitted for 40/120 min and 12 h to the following treatments: C: RPMI + DMSO; R: RPMI + Ral; G: RPMI + Ral + G15 (GPER1 antagonist). Trypan blue staining measured cell viability. Migratory potential (12 h) was measured by transwell migration test in translucent inserts, which were then stained with DAPI and analysed under a fluorescence microscope for quantification. Cells from 40- and 120-min treatments were subjected to protein extraction to the study of AKT, pAKT, ERK, pERK, ERβ and SIRT1. Key findings: There is a reduction in cellular viability in R compared to C at all evaluated times, and an increased cell viability in G when compared to R; cell viability was similar in C and G in all times studied. The migration assay demonstrated a significant decrease in migration potential of tumour cells in R compared to C and G. Ral treatment reduced pERK expression and increased pAKT in the treated groups after 40 min, pointing out to an antiproliferative and apoptotic effect in the GPER1-controlled rapid-effect pathways. Conclusions: Raloxifene was able to modulate GPER1 in LNCaP prostate tumour cells, decreasing cell viability and their migratory potential.


  • Protective effect of resveratrol on urogenital sinus and prostate development in rats exposed in utero to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin)

    by Lívia Teresa Ribeiro Silveira, Talita de Mello Santos, Lucas Fredini Camora, Cristiane Figueiredo Pinho, Janete A. Anselmo-Franci, Raquel Fantin Domeniconi, Luis Antonio Justulin, Luis Fernando Barbisan, Wellerson Rodrigo Scarano


  • Cell junctions in the prostate: an overview about the effects of Endocrine Disrupting Chemicals (EDCS) in different experimental models

    by Wellerson R. Scarano, Cristiane F. Pinho, Lorenzo Pissinatti, Bianca F. Gonçalves, Leonardo O. Mendes, Silvana G.P. Campos


  • Modulation of inflammatory and hormonal parameters in response to testosterone therapy: Effects on the ventral prostate of adult rats

    by Leonardo O. Mendes, Anthony C. S. Castilho, Cristiane F. Pinho, Bianca F. Gonçalvez, Eduardo M. Razza, Luiz Gustavo A. Chuffa, Janete A. Anselmo‐Franci, Wellerson R. Scarano, Francisco E. Martinez

    Testosterone is often recommended in the treatment of several aging‐related conditions. However, there are still questions about the consequences of this therapy in terms of hormonal and inflammatory parameters that are crucial for prostate homeostasis. Thus, we investigate if the testosterone therapy (TT) modulates the hormone receptors and inflammatory cytokines in the ventral prostate of adult rats. Wistar rats aging 150 days were divided into two experimental groups (n = 10/group): T: received subcutaneous injections of testosterone cypionate (5 mg/kg body weight) diluted in corn oil every other day for 4 weeks; and C: received corn oil as vehicle. Animals were euthanized at 180 days old by decapitation. Blood was collected to obtain hormone and cytokines concentrations. The ventral prostate was dissected and processed for light microscope and molecular analyses. Relative ventral prostate weight and epithelial compartment were increased after TT. The number of intact and degranulated mast cells was reduced in the T group. Plasma testosterone, DHT and intraprostatic testosterone concentrations were higher in the T group. TT leads to an increase in cell proliferation and up‐regulation of AR, ERβ, PAR‐4, and NRF2. Importantly, plasma concentration and tissue expression of IL‐10 and TNF‐α were higher after TT. In summary, these results indicate that TT can regulate inflammatory response, with impacts in cytokines and mast cell population, and modulates steroids receptors, important parameters for prostatic homeostasis.


  • Combinatorial Effect of Abiraterone Acetate and NVP-BEZ235 on Prostate Tumor Progression in Rats

    by Bianca Facchim Gonçalves, Silvana Gisele Pegorin de Campos, Wagner José Fávaro, Joyce Zalotti Brandt, Cristiane Figueiredo Pinho, Luis Antônio Justulin, Sebastião Roberto Taboga, Wellerson Rodrigo Scarano

    Use of drug combinations that target different pathways involved in the development and progression of prostate cancer (PCa) has emerged as an alternative to overcome the resistance caused by drug monotherapies. The antiandrogen abiraterone acetate and the PI3K/Akt inhibitor NVP-BEZ235 (BEZ235) may be suitable options for the prevention of drug resistance and the inhibition of PCa progression. The aim of the present study was to evaluate whether abiraterone acetate and BEZ235 achieve superior therapeutic effects to either drug administered as monotherapy, in the early stages of PCa in an androgen-dependent system. Our study showed that each drug might impair tumor growth by reducing proliferation and increasing cell death when administered as monotherapy. However, tumor growth continued to progress with each drug monotherapy and some important side effects were related to BEZ. Conversely, when used in combination, the drugs impaired the inflammatory response, decreased hyperplastic lesions, and blocked tumor progression from premalignant to a malignant stage. Our data showed that the strategy to block the androgenic and PI3K/AKT/mTOR pathway is an effective therapeutic option and should be investigated including distinct PI3K pathway inhibitors.


  • Regulatory and junctional proteins of the blood-testis barrier in human Sertoli cells are modified by monobutyl phthalate (MBP) and bisphenol A (BPA) exposure

    by André Teves Aquino Gonçalves de Freitas, Mariana Antunes Ribeiro, Cristiane Figueiredo Pinho, André Rebelo Peixoto, Raquel Fantin Domeniconi, Wellerson R. Scarano


  • Gestational protein restriction delays prostate morphogenesis in male rats

    by Cristiane F. Pinho, Mariana A. Ribeiro, Jaqueline C. Rinaldi, Sergio L. Felisbino, Patricia F. Pinheiro, Raquel F. Domeniconi, Ricardo A. Fochi, Patrícia A. Boer, Wellerson R. Scarano

    Maternal malnutrition due to a low-protein diet is associated with functional disorders in adulthood, which may be related to embryonic development failures. The effects of gestational protein restriction on prostate morphogenesis in male offspring were investigated. Pregnant rat dams were divided into normoprotein (NP; fed a normal diet containing 17% protein) and hypoprotein (LP; fed a diet containing 6% protein) groups. On the day of birth (PND1), anogenital distance and bodyweight were measured in male pups. Seven males per experimental group (one male per litter) were killed, and the pelvic urethra was evaluated. LP offspring showed a significant reduction in bodyweight and anogenital distance on PND1. On three-dimensional reconstruction of the prostate, the number of prostatic buds was lower in LP than in NP males. Mesenchymal cells surrounding the buds were androgen-receptor positive, and the quantity and intensity of nucleus immunoreactivity was decreased in LP. The proliferation index was lower in LP than in NP prostatic buds. Immunoreactivity for a-actin in mesenchymal cells and that for epidermal growth factor receptor in epithelial cells was higher in NP than in LP. Our findings demonstrate that maternal protein restriction delays prostatic morphogenesis, probably because of considerable disruption in the epithelium–mesenchyme interaction.